- Visibility 255 Views
- Downloads 218 Downloads
- Permissions
- DOI 10.18231/j.jpmhh.v.11.i.1.4
-
CrossMark
- Citation
Ayurvedic approaches for the prevention and treatment of coronary artery disease: Moving from theory to clinical practice
The incidence and mortality rates of coronary artery disease (CAD) are rising in India, with a significant shift towards younger population in between the age of 30 to 60 years. Ayurveda classical texts described Hrudroga (heart disease) and Hrudshoola (angina) as a sudden, sharp pain occurring in the heart region based on tridosha theory. Actually hrudshoola (Angina) is a symptom of CAD and Vata, Kapha and Meda dhatu (adipose tissue) involved in pathogenesis of CAD. Hridya mohakasaya of Charak Samhita was ignored and the food, beverage, fruits and vegetables described in Ayurveda were remains as theory for practitioners. The most used Ayurvedic bio active molecules of cardiac medical plants like- Arjuna, Lasuna, Sarpagandha, Daruharidra, Garcinia, Curcumin etc are cardioprotective in terms of Pharmacological study and clinical trials for CAD. The Ayurveda formulations described different texts were in ambiguous practice in past. The patients were also generally hesitant to seek heart disease treatment from Vaidyas, Ayurvedic physicians were only focused on classical theoretical knowledge rather than modern understanding of heart diseases and clinical practice. In recent times, Ayurvedic medicines are gaining attention as potential adjunct therapies, particularly for their roles in alleviating angina, offering lipid-lowering effects, and providing anti-thrombotic benefits. These therapeutic approaches could complement to standard treatments, potentially enhancing symptom relief and improving overall survival outcomes of CAD. Ayurveda can also independently reverse coronary architecture of stable angina, completely eliminate the need for preventive modern medications in some cases. Arjuna (Arjuna (Terminalia arjuna) preparations are found best in CAD. So Ayurvedic strategies for the prevention and management of coronary artery disease (CAD) have transitioned from classical theoretical foundations to implementation in clinical settings, but more enthusiastic and dedicated Ayurveda scholars should come forward to create more evidences.
References
- Krishnan MN. Coronary heart disease and risk factors in India - on the brink of an epidemic? Indian Heart J. 2012;64(4):364-7.
- Bottardi A, Prado GFA, Lunardi M, Fezzi S, Pesarini G, Tavella D, Scarsini R, Ribichini F. Clinical Updates in Coronary Artery Disease: A Comprehensive Review. J Clin Med. 2024;13(16):4600.
- Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel M.R. et al. Prognostic Value of Non invasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Circulation. 2017;135:2320–32.
- Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754-63.
- Anand A, Tyagi R, Kaur P. Incubating Integrative Medicine in India through PMO's Atal Incubator Scheme of Niti Aayog. Ann Neurosci. 2017;24(3):131-3.
- Arnett DK, Blumenthal RS, Albert MA. ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646
- Rehman S, Khan A, Rehman A. Physiology, Coronary Circulation.In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025
- Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Martín C. Pathophysiology of Atherosclerosis. Int J Mol Sci. 2022;23(6):3346.
- Short L, La VT, Patel M, Pai RG. Primary and Secondary Prevention of CAD: A Review. Int J Angiol. 2021;31(1):16-26.
- Murthy AR, Singh RH. Ayurvedic concept of hridroga its present relevance. Anc Sci Life. 1993;12(3-4):403-13.
- Chaudhary, K., Kaushal, K., & Kaswan, S.K. Evaluation of Hridya Mahakashaya of Charak Samhita in CVS :- A Literary Review. Int Res J Ayurveda & Yoga, 2022;5(8):138-44.
- Indu S. A Review on the concept of Hridya in Ayurveda: Looking beyond Cardio tonics. Int J Res Ayurveda Pharm. 2021;12(3):88-94.
- Kaur Jaswinder., et al. “An Overview on Renowned Traditional Ancient Plant: Terminalia arjuna”. APJHS; 2021;8(4):25-32.
- Rabito MJ, Kaye AD. Complementary and alternative medicine and cardiovascular disease: an evidence-based review. Evid Based Complement Alternat Med. 2013;2013:672097.
- Panda A.K, The incidence and clinical profile of Heart diseases in Ayurveda Hospital presented at 75th Annual Conference Cardiological society of India, in Kolkata, West Bengal, from December 7-10, 2023
- DuBroff R, Lad V, Murray-Krezan C. A Prospective Trial of Ayurveda for Coronary Heart Disease: A Pilot Study. Altern Ther Health Med. 2015;21(5):52-62.
- Kaware , Rupali, and Sadik Khan. “Role of Ayurveda-Based Diet and Panchakarma Therapy on Quantitative Change in Coronary Atherosclerosis in Known CAD Assessed by Quantitative CT Coronary Angiography. Asian J Cardiol Res. 2023;6(1):125-31 22 Panda and Kar/ Journal of Preventive Medicine and Holistic Health2025;11(1):16-22
- Sharma H, Swetanshu, Singh P. Role of Yoga in Cardiovascular Diseases. Curr Probl Cardiol. 2024;49(1 Pt A):102032.
- Manchanda SC, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103(9):675-80.
- Murtagh EM, Murphy MH, Boone-Heinonen J. Walking: the first steps in cardiovascular disease prevention. Curr Opin Cardiol. 2010;25(5):490-6.
- Panda AK, Kar S. Panchakarma-Based Detoxification Procedures Can Regulate the Hepato-renal Dysfunction: A Case Study. Int J AYUSH Case Rep. 2023;7(2):103-110.
- Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Front Pharmacol. 2020;11:422.
- Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-7.
- Rohit S, Pramod M, Rahul M, Gurudatta A, Pravin G, Dinesh P. Impact of Ayurveda-based Ischemia Reversal Program on Reduction of Resting Myocardial Ischemia Studied with Speckle- Tracking Global Longitudinal Strain Imaging. J Indian College Cardiol. 2022;12(3):106-10.
- Rohit S, Hanchate M. “Effect of the Sampurna Hriday Shuddhikaran (SHS) Model in Heart Failure Patients in India: A Prospective Study”. J Advanc Med Med Res. 2013;4(1):564-71.
- Levine GN, Lange RA, Bairey-Merz CN, Davidson RJ, Jamerson K, Mehta PK. American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2017;6(10):e002218.
- Ajay kumar sharma, shashi mohan sharma, suneet prakash sharma, amit kumar sharma. Management of Stable Angina with Lasunadi Guggulu-An Ayurvedic Formulation. AAM. 2012;1(1-2):15-21.
- Khaliq F, Fahim M: Role of Terminalia arjuna in improving cardiovascular functions: a review. Indian J Physiol Pharmacol. 2018;62:8-19.
- Kaur N, Shafiq N, Negi H, Pandey A, Reddy S, Kaur H, Chadha N, Malhotra S. Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis. Cardiol Res Pract. 2014;2014:281483.
- Maulik SK, Talwar KK. Therapeutic potential of Terminalia arjuna in cardiovascular disorders. Am J Cardiovasc Drugs. 2012;12(3):157-63.
- Rui R, Yang H, Liu Y, Zhou Y, Xu X, Li C, Liu S. Effects of Berberine on Atherosclerosis. Front Pharmacol. 2021;12:764175
- Bhatt N. Cardio protective property of Rhododendron arboreum. Can J Clin Nutr. 2018:186–94.
- Pradhan A, Chakraborty M, Lepcha O. Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin- induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers. Clin Phytosci. 2023;9(1):1-10.
- Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas). 2015;14(3):40-6.
- Patel KJ, Panchasara AK, Barvaliya MJ, Purohit BM, Baxi SN, Vadgama VK. Evaluation of cardioprotective effect of aqueous extract of Garcinia indica Linn. fruit rinds on isoprenaline-induced myocardial injury in Wistar albino rats. Res Pharm Sci.2025;10(5):388-96.
- Laddha AP, Chawda MB, Kulkarni YA. Cardioprotective effect of Hrudroga Chintamani Rasa in isoproterenol induced cardiotoxicity in male Sprague Dawley rats. J Diabetes Metab Disord. 2022;21(2):1261-70.
How to Cite This Article
Vancouver
Kar S, Panda AK. Ayurvedic approaches for the prevention and treatment of coronary artery disease: Moving from theory to clinical practice [Internet]. J Prev Med Holist Health. 2025 [cited 2025 Sep 30];11(1):16-22. Available from: https://doi.org/10.18231/j.jpmhh.v.11.i.1.4
APA
Kar, S., Panda, A. K. (2025). Ayurvedic approaches for the prevention and treatment of coronary artery disease: Moving from theory to clinical practice. J Prev Med Holist Health, 11(1), 16-22. https://doi.org/10.18231/j.jpmhh.v.11.i.1.4
MLA
Kar, S, Panda, Ashok Kumar. "Ayurvedic approaches for the prevention and treatment of coronary artery disease: Moving from theory to clinical practice." J Prev Med Holist Health, vol. 11, no. 1, 2025, pp. 16-22. https://doi.org/10.18231/j.jpmhh.v.11.i.1.4
Chicago
Kar, S., Panda, A. K.. "Ayurvedic approaches for the prevention and treatment of coronary artery disease: Moving from theory to clinical practice." J Prev Med Holist Health 11, no. 1 (2025): 16-22. https://doi.org/10.18231/j.jpmhh.v.11.i.1.4